Dave Mawhinney is Co-Director of the Carnegie Mellon Center for Innovation and Entrepreneurship at Carnegie Mellon University, as well as the Executive Director of the Donald H. Jones Center for Entrepreneurship, Managing Director of the Open Field Entrepreneurs Fund, and Associate Teaching Professor at CMU'sTepper School of Business. He is also Director of the i6 Agile Innovation System, a joint venture between Carnegie Mellon University and Innovation Works, designed to accelerate the commercialization of technologies being developed within the region's universities and small businesses that can be duplicated throughout the nation.
Prior to joining Carnegie Mellon, Dave was co-founder, Chairman and CEO of mSpoke, an internet content and advertising recommendation engine, which was acquired in 2010 by LinkedIn, the world’s leading professional social networking site. In 2006, Morgan Stanley’s MSCI/Barra business unit acquired mSpoke’s first business line, a quantitative investment recommendation engine.
Before mSpoke, Dave was General Partner of PNC Technology Investors. Earlier in his career, he co-founded three successful startup ventures, including Premier Health Exchange (acquired by Medibuy), Hawk Medical (acquired by McKesson), and Industry.Net (merged with AT&T Business Network to form Nets, Inc.).
Dave is an active Board Member at MedSage Technologies (now NewCare Solutions LLC), EZ-FLO Injection Systems, and the Indiana University of Pennsylvania Alumni Association (ex-officio, Past President). He is an Advisory Board Member to InnovationWork’s AlphaLab, Pittsburgh Equity Partners, and Carnegie Mellon University’s Project Olympus. Dave also served as Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, working with healthcare information technology start-ups.
He holds an MBA with Distinction from Carnegie Mellon University and a B.S. in Physics, Summa Cum Laude, from Indiana University of Pennsylvania.
Back to Advisory Board
Prior to joining Carnegie Mellon, Dave was co-founder, Chairman and CEO of mSpoke, an internet content and advertising recommendation engine, which was acquired in 2010 by LinkedIn, the world’s leading professional social networking site. In 2006, Morgan Stanley’s MSCI/Barra business unit acquired mSpoke’s first business line, a quantitative investment recommendation engine.
Before mSpoke, Dave was General Partner of PNC Technology Investors. Earlier in his career, he co-founded three successful startup ventures, including Premier Health Exchange (acquired by Medibuy), Hawk Medical (acquired by McKesson), and Industry.Net (merged with AT&T Business Network to form Nets, Inc.).
Dave is an active Board Member at MedSage Technologies (now NewCare Solutions LLC), EZ-FLO Injection Systems, and the Indiana University of Pennsylvania Alumni Association (ex-officio, Past President). He is an Advisory Board Member to InnovationWork’s AlphaLab, Pittsburgh Equity Partners, and Carnegie Mellon University’s Project Olympus. Dave also served as Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, working with healthcare information technology start-ups.
He holds an MBA with Distinction from Carnegie Mellon University and a B.S. in Physics, Summa Cum Laude, from Indiana University of Pennsylvania.
Back to Advisory Board
